Helios Logo

Struggling to control diabetes despite GLP-1 treatment?

Adults with uncontrolled diabetes while on GLP-1 injections may qualify for research.

A clinical study is looking for adults who have been using a GLP-1 injection, at a stable dosage, for at least 3 months but still have elevated HbA1c. See if you qualify for research exploring potential treatment options.

Required
Required
Required
Required
Please enter 10 digits for phone number. Required when opting in to SMS.
You must consent to the privacy policy.
If you consent to SMS messages, you must provide a phone number.

Purpose of the Study

The purpose of this study is to evaluate potential treatment strategies for those who have been using a GLP-1 injection, at a stable dosage, for at least 3 months but continue to experience high HbA1c levels.

Study Requirements

You may qualify if you:

    o Are 18 years or older
    o Have been using an injectable GLP-1 therapy, at a stable dosage, for at least 3 months
    o Still have an elevated HbA1c

Potential Benefits of Participation

Icon 1

Access to new treatments that are not yet available to the general public.

Icon 2

Personalized medical attention from leading healthcare professionals.

Icon 3

Compensation up to $2910.00 may be provided for study-related time and travel

Study Locations

This study is currently enrolling at the following sites:

    Helios Clinical Research - Phoenix, AZ (4600 East Shea Boulevard, 85028)

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.

Privacy Policy Current Studies Helios Highlights
We Know Time is Precious

© 2024 Helios Clinical. All rights reserved.